![Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors]()
Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumorsDahut, William L.; Lakhani, Nehal J.; Gulley, James L.; Arlen, Philip M.; Kohn, Elise C.; Kotz, Herbert; McNally, Debbie; Parr, Allyson; Parr, Allyson; Nguyen, Diana; Yang, Sherry X.; Steinberg, Seth M.; Venitz, Jürgen; Sparreboom, Alex; Figg, II, William · Cancer Biology & Therapy · 2006